A two-drug combination for metastatic melanoma reduced the odds of progression by 60 percent, demonstrating more effectiveness than monotherapy, according to researchers.
Tips to Organize the Digital Chaos with Alina Bridges, DO
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Expert Tips on Alopecia Management From AAD 2023
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Treating Body Dysmorphic Disorder in Cosmetic Patients
Isotretinoin Best Practices: New Formulations, Avoiding Relapses, and More
2 Clarke Drive Cranbury, NJ 08512